Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | TYR | P14679 | 1/20 | 0.63 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.55 |
| ▸ | GLRB | P48167 | 1/20 | 0.55 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29623812 | 1.00 | SMN1; SMN2 (0.63) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL11773023 | 0.98 | SMN1; SMN2 (0.61) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL7198879 | 0.86 | SMN1; SMN2 (0.65) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL17500078 | 0.85 | SMN1; SMN2 (0.63) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL7636127 | 0.85 | SMN1; SMN2 (0.63) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL25564616 | 0.83 | CSNK2A1 (0.44) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL8747786 | 0.83 | SMN1; SMN2 (0.61) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL39336 | 0.82 | GLRA3 (0.57) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL28898246 | 0.82 | SMN1; SMN2 (0.55) | SMN1; SMN2CA2ALDH1A1POLBTYR | |
| SCHEMBL9250721 | 0.82 | ALDH1A1 (0.41) | SMN1; SMN2CA2ALDH1A1POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144729-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| EP-4611719-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2025-09-10 | — | — | EP | claimed |
| CN-120076784-A | Cleaning composition | 莱雅公司 | 2025-05-30 | — | — | CN | claimed |
| WO-2024092386-A1 | A CLEANSING COMPOSITION | L'OREAL (FR) | 2024-05-10 | — | — | WO | claimed |
| US-8974804-B2 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2015-03-10 | — | — | US | claimed |
| US-20120301414-A1 | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND USES THEREOF | L'OREAL (FR) | 2012-11-29 | — | — | US | claimed |
| EP-1415645-B1 | Composition in the form of an oil-in-water emulsion and its cosmetic uses | OREAL (FR) | 2007-10-03 | — | — | EP | claimed |
| US-6835517-B2 | Mixture of binder, colorant, charge control agent and wax; electrostatic latent images | RICOH COMPANY, LTD. (JP) | 2004-12-28 | — | — | US | claimed |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | L'OREAL (FR) | 2004-08-26 | — | — | US | claimed |
| US-4910021-A | Oral administered coated capsule for colonic absorption | R. P. SCHERER CORPORATION (US) | 1990-03-20 | — | — | US | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4464363-A | HYDROXY ARYL- OR HYDROXY ARALKYL ACIDS OR SALTS | MERCK & CO., INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4462991-A | POLYPEPTIDE ADJUVANTS OF CARBOXY- OR SULFOSUBSTITUTED PHENOLS | INTERX RESEARCH CORP. (US) | 1984-07-31 | — | — | US | claimed |
| US-4459295-A | Method of increasing oral absorption of glycosidic and related antibiotics | INTERX RESEARCH CORPORATION (US) | 1984-07-10 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| US-4121013-A | 3,5-SUBSTITUTED SALICYLIC ACID, ZINC COMPOUND, AMMONIUM HYDROXIDE, COATINGS, SENSITIZED FOR COLOR DEVELOPMENT | NCR CORPORATION (US) | 1978-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120301414-A1 | COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION AND USES THEREOF | PLOD3, CUTA, LOXL1 | SMN1; SMN2 1549/4885CA2 4668/4885ALDH1A1 1155/4885 |
| US-20040166128-A1 | Composition in the form of an oil-in-water emulsion and uses thereof | PLOD3, CUTA, LOXL1 | SMN1; SMN2 1549/4885CA2 4668/4885ALDH1A1 1155/4885 |
| US-20260144729-A1 | A CLEANSING COMPOSITION | SMURF1, CUTA, S100B | SMN1; SMN2 1451/4885CA2 1445/4885ALDH1A1 780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.